P.A.W. Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

P.A.W. Capital’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-35,000	Closed	-$833K	–	73
2016 Q3	$833K	Sell	35,000 -15,000	-30%	-$283K	0.9%	33
2016 Q2	$800K	Sell	50,000 -4,000	-7%	-$71.8K	0.92%	36
2016 Q1	$1.13M	Buy	54,000 +3,600	+7%	+$64.2K	1.27%	28
2015 Q4	$1.36M	Buy	50,400 +2,400	+5%	+$65.4K	1.54%	28
2015 Q3	$1.33M	Sell	48,000 -7,000	-13%	-$221K	1.53%	25
2015 Q2	$1.35M	Buy	55,000 +15,000	+38%	+$309K	1.36%	30
2015 Q1	$732K	Buy	40,000 +15,000	+60%	+$304K	0.72%	43
2014 Q4	$461K	Buy	+25,000	New	+$297K	0.49%	62

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

P.A.W. Capital's LJPC Position: Q4 2016 in Review

P.A.W. Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2016, closing a stake of 35,000 shares — an estimated $833K sold.

P.A.W. Capital first reported a position in LJPC in Q4 2014 and held it in 8 quarters. The position peaked at $1.36M in Q4 2015. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

P.A.W. Capital reported no remaining La Jolla Pharmaceutical Company position as of Q4 2016 after selling out during the quarter.
P.A.W. Capital sold 35,000 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $833K.
P.A.W. Capital first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and held it in 8 quarters.
P.A.W. Capital's La Jolla Pharmaceutical Company position peaked at $1.36M in Q4 2015.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on P.A.W. Capital's 13F filing for Q4 2016, filed 25 Jan 2017.